Fat deposition and accumulation in the damaged and inflamed skeletal muscle: Cellular and molecular players

Cellular and Molecular Life Sciences

Volumn 72, Issue 11, 2015, Pages 2135-2156

  Sciorati, Clara ^a   Clementi, Emilio ^b,c   Manfredi, Angelo A ^a,d   Rovere Querini, Patrizia ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Adipogenesis; Fat; Fibro adipogenic precursor; Mesenchymal cells; Nitric oxide; Satellite cells; Skeletal muscle

Indexed keywords

COLLAGEN; KRUPPEL LIKE FACTOR; PEG3 PROTEIN, HUMAN;

ADIPOCYTE; ADIPOGENESIS; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CYTOLOGY; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; IMMUNOLOGY; INJURIES; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL;

ADIPOCYTES; ADIPOGENESIS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; COLLAGEN; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MESENCHYMAL STROMAL CELLS; MUSCLE, SKELETAL; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 84938096484     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-015-1857-7     Document Type: Article

References (246)

1. Charge SB, Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238
2. Kuang S, Rudnicki MA (2008) The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med 14:82-91
3. Relaix F, Zammit PS (2012) Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139:2845-2856
4. Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93:23-67
5. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA (2000) Pax7 is required for the specification of myogenic satellite cells. Cell 102:777-786
6. Zammit PS, Relaix F, Nagata Y, Ruiz AP, Collins CA, Partridge TA, Beauchamp JR (2006) Pax7 and myogenic progression in skeletal muscle satellite cells. J Cell Sci 119:1824-1832
7. Halevy O, Piestun Y, Allouh MZ, Rosser BW, Rinkevich Y, Reshef R, Rozenboim I, Wleklinski-Lee M, Yablonka-Reuveni Z (2004) Pattern of Pax7 expression during myogenesis in the posthatch chicken establishes a model for satellite cell differentiation and renewal. Dev Dyn 231:489-502
8. Cusella-De Angelis MG, Lyons G, Sonnino C, De Angelis L, Vivarelli E, Farmer K, Wright WE, Molinaro M, Bouche M, Buckingham M et al (1992) MyoD, myogenin independent differentiation of primordial myoblasts in mouse somites. J Cell Biol 116:1243-1255
9. Collins CA, Partridge TA (2005) Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle 4:1338-1341
10. Oustanina S, Hause G, Braun T (2004) Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J 23:3430-3439
11. Relaix F, Montarras D, Zaffran S, Gayraud-Morel B, Rocancourt D, Tajbakhsh S, Mansouri A, Cumano A, Buckingham M (2006) Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J Cell Biol 172:91-102
12. Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D, Relaix F (2003) The formation of skeletal muscle: from somite to limb. J Anat 202:59-68
13. Kuang S, Charge SB, Seale P, Huh M, Rudnicki MA (2006) Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J Cell Biol 172:103-113
14. Davis RL, Weintraub H, Lassar AB (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000
15. Rudnicki MA, Braun T, Hinuma S, Jaenisch R (1992) Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71:383-390
16. Braun T, Rudnicki MA, Arnold HH, Jaenisch R (1992) Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71:369-382
17. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1359
18. Zhang W, Behringer RR, Olson EN (1995) Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev 9:1388-1399
19. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, Olson EN, Klein WH (1993) Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364:501-506
20. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nonaka I (1993) Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364:532-535
21. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H (1991) Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315
22. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB et al (1989) Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544
23. Jen Y, Weintraub H, Benezra R (1992) Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev 6:1466-1479
24. Rao SS, Chu C, Kohtz DS (1994) Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol 14:5259-5267
25. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021
26. Lu J, Webb R, Richardson JA, Olson EN (1999) MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Proc Natl Acad Sci U S A 96:552-557
27. Lemercier C, To RQ, Carrasco RA, Konieczny SF (1998) The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD. EMBO J 17:1412-1422
28. Postigo AA, Dean DC (1997) ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation. EMBO J 16:3935-3943
29. Chen CM, Kraut N, Groudine M, Weintraub H (1996) I-mf, a novel myogenic repressor, interacts with members of the MyoD family. Cell 86:731-741
30. Li L, Heller-Harrison R, Czech M, Olson EN (1992) Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol Cell Biol 12:4478-4485
31. Li L, Zhou J, James G, Heller-Harrison R, Czech MP, Olson EN (1992) FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71:1181-1194
32. Hashimoto N, Ogashiwa M, Okumura E, Endo T, Iwashita S, Kishimoto T (1994) Phosphorylation of a proline-directed kinase motif is responsible for structural changes in myogenin. FEBS Lett 352:236-242
33. Song A, Wang Q, Goebl MG, Harrington MA (1998) Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol 18:4994-4999
34. Ono K, Han J (2000) The p38 signal transduction pathway: activation and function. Cell Signal 12:1-13
35. Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko VV, Howard BH, Kedes L, Wang JY, Graessmann A, Nakatani Y, Levrero M (1997) Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1:35-45
36. Edmondson DG, Lyons GE, Martin JF, Olson EN (1994) Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120:1251-1263
37. Kaushal S, Schneider JW, Nadal-Ginard B, Mahdavi V (1994) Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 266:1236-1240
38. Martin JF, Miano JM, Hustad CM, Copeland NG, Jenkins NA, Olson EN (1994) A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol Cell Biol 14:1647-1656
39. Naidu PS, Ludolph DC, To RQ, Hinterberger TJ, Konieczny SF (1995) Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol Cell Biol 15:2707-2718
40. Cserjesi P, Olson EN (1991) Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol 11:4854-4862
41. Sambasivan R, Yao R, Kissenpfennig A, Van Wittenberghe L, Paldi A, Gayraud-Morel B, Guenou H, Malissen B, Tajbakhsh S, Galy A (2011) Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 138:3647-3656
42. Lepper C, Partridge TA, Fan CM (2011) An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138:3639-3646
43. Brunelli S, Rovere-Querini P (2008) The immune system and the repair of skeletal muscle. Pharmacol Res 58:117-121
44. Saclier M, Yacoub-Youssef H, Mackey AL, Arnold L, Ardjoune H, Magnan M, Sailhan F, Chelly J, Pavlath GK, Mounier R, Kjaer M, Chazaud B (2013) Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells 31:384-396
45. Rhoads RP, Johnson RM, Rathbone CR, Liu X, Temm-Grove C, Sheehan SM, Hoying JB, Allen RE (2009) Satellite cell-mediated angiogenesis in vitro coincides with a functional hypoxia-inducible factor pathway. Am J Physiol Cell Physiol 296:C1321-C1328
46. Abou-Khalil R, Mounier R, Chazaud B (2010) Regulation of myogenic stem cell behavior by vessel cells: the "menage a trois" of satellite cells, periendothelial cells and endothelial cells. Cell Cycle 9:892-896
47. DiMario J, Buffinger N, Yamada S, Strohman RC (1989) Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 244:688-690
48. Chen X, Li Y (2009) Role of matrix metalloproteinases in skeletal muscle: migration, differentiation, regeneration and fibrosis. Cell Adh Migr 3:337-341
49. Ceafalan LC, Popescu BO, Hinescu ME (2014) Cellular players in skeletal muscle regeneration. Biomed Res Int 2014:957014
50. Rinaldi F, Perlingeiro RC (2013) Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks. Transl Res 163:409-417
51. Asakura A (2003) Stem cells in adult skeletal muscle. Trends Cardiovasc Med 13:123-128
52. Lewis SF, Haller RG (1989) Skeletal muscle disorders and associated factors that limit exercise performance. Exerc Sport Sci Rev 17:67-113
53. Barany M, Venkatasubramanian PN, Mok E, Siegel IM, Abraham E, Wycliffe ND, Mafee MF (1989) Quantitative and qualitative fat analysis in human leg muscle of neuromuscular diseases by 1H MR spectroscopy in vivo. Magn Reson Med 10:210-226
54. Vettor R, Milan G, Franzin C, Sanna M, De Coppi P, Rizzuto R, Federspil G (2009) The origin of intermuscular adipose tissue and its pathophysiological implications. Am J Physiol Endocrinol Metab 297:E987-E998
55. Schulz TJ, Huang TL, Tran TT, Zhang H, Townsend KL, Shadrach JL, Cerletti M, McDougall LE, Giorgadze N, Tchkonia T, Schrier D, Falb D, Kirkland JL, Wagers AJ, Tseng YH (2010) Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci U S A 108:143-148
56. Virtanen KA, Nuutila P (2010) Brown adipose tissue in humans. Curr Opin Lipidol 22:49-54
57. Triplett WT, Baligand C, Forbes SC, Willcocks RJ, Lott DJ, DeVos S, Pollaro J, Rooney WD, Sweeney HL, Bonnemann CG, Wang DJ, Vandenborne K, Walter GA (2013) Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle. Magn Reson Med 72:8-19
58. Chan WP, Liu GC (2002) MR imaging of primary skeletal muscle diseases in children. AJR 179:989-997
59. Reimers CD, Finkenstaedt M (1997) Muscle imaging in inflammatory myopathies. Curr Opin Rheumatol 9:475-485
60. Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M, Newman AB, Goodpaster BH (2009) Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 90:1579-1585
61. Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB (2007) Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr 85:377-384
62. Gargiulo P, Kern H, Carraro U, Ingvarsson P, Knutsdottir S, Gudmundsdottir V, Yngvason S, Vatnsdal B, Helgason T (2010) Quantitative color three-dimensional computer tomography imaging of human long-term denervated muscle. Neurol Res 32:13-19
63. Gorgey AS, Dudley GA (2007) Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord 45:304-309
64. Song MY, Ruts E, Kim J, Janumala I, Heymsfield S, Gallagher D (2004) Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr 79:874-880
65. Kohrt WM, Holloszy JO (1995) Loss of skeletal muscle mass with aging: effect on glucose tolerance. J Gerontol A Biol Sci Med Sci 50:68-72
66. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield SB, Goodpaster B, Visser M, Harris TB (2005) Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 81:903-910
67. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E (2002) Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51:144-151
68. Hilton TN, Tuttle LJ, Bohnert KL, Mueller MJ, Sinacore DR (2008) Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther 88:1336-1344
69. Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S, Bottari A, Vita G, Settineri N, Bruschetta D, Racchiusa S, Minutoli F (2010) Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol 41:955-961
70. Yao L, Gai N (2012) Fat-corrected T2 measurement as a marker of active muscle disease in inflammatory myopathy. AJR 198:W475-W481
71. Kim HK, Merrow AC, Shiraj S, Wong BL, Horn PS, Laor T (2013) Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging and correlation with clinical assessments. Pediatr Radiol 43:1327-1335
72. Marden FA, Connolly AM, Siegel MJ, Rubin DA (2005) Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 34:140-148
73. Wren TA, Bluml S, Tseng-Ong L, Gilsanz V (2008) Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR 190:W8-12
74. Pisani DF, Bottema CD, Butori C, Dani C, Dechesne CA (2010) Mouse model of skeletal muscle adiposity: a glycerol treatment approach. Biochem Biophys Res Commun 396:767-773
75. Fukada S, Morikawa D, Yamamoto Y, Yoshida T, Sumie N, Yamaguchi M, Ito T, Miyagoe-Suzuki Y, Takeda S, Tsujikawa K, Yamamoto H (2010) Genetic background affects properties of satellite cells and mdx phenotypes. Am J Pathol 176:2414-2424
76. Lukjanenko L, Brachat S, Pierrel E, Lach-Trifilieff E, Feige JN (2013) Genomic profiling reveals that transient adipogenic activation is a hallmark of mouse models of skeletal muscle regeneration. PLoS One 8:e71084
77. Wagatsuma A (2007) Adipogenic potential can be activated during muscle regeneration. Mol Cell Biochem 304:25-33
78. Joe AW, Yi L, Natarajan A, Le Grand F, So L, Wang J, Rudnicki MA, Rossi FM (2010) Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 12:153-163
79. Uezumi A, Ikemoto-Uezumi M, Tsuchida K (2014) Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle. Front Physiol 5:68
80. Liu W, Liu Y, Lai X, Kuang S (2011) Intramuscular adipose is derived from a non-Pax3 lineage and required for efficient regeneration of skeletal muscles. Dev Biol 361:27-38
81. Sun L, Nicholson AC, Hajjar DP, Gotto AM Jr, Han J (2003) Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line. J Lipid Res 44:1877-1886
82. Kuang S, Gillespie MA, Rudnicki MA (2008) Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2:22-31
83. Kuang S, Kuroda K, Le Grand F, Rudnicki MA (2007) Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129:999-1010
84. Beauchamp JR, Heslop L, Yu DS, Tajbakhsh S, Kelly RG, Wernig A, Buckingham ME, Partridge TA, Zammit PS (2000) Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151:1221-1234
85. Hu E, Tontonoz P, Spiegelman BM (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci U S A 92:9856-9860
86. Asakura A, Komaki M, Rudnicki M (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68:245-253
87. Shefer G, Wleklinski-Lee M, Yablonka-Reuveni Z (2004) Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway. J Cell Sci 117:5393-5404
88. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument-Bromage H, Tempst P, Rudnicki MA, Beier DR, Spiegelman BM (2008) PRDM16 controls a brown fat/skeletal muscle switch. Nature 454:961-967
89. Csete M, Walikonis J, Slawny N, Wei Y, Korsnes S, Doyle JC, Wold B (2001) Oxygen-mediated regulation of skeletal muscle satellite cell proliferation and adipogenesis in culture. J Cell Physiol 189:189-196
90. Scarda A, Franzin C, Milan G, Sanna M, Dal Pra C, Pagano C, Boldrin L, Piccoli M, Trevellin E, Granzotto M, Gamba P, Federspil G, De Coppi P, Vettor R (2010) Increased adipogenic conversion of muscle satellite cells in obese Zucker rats. Int J Obes (Lond) 34:1319-1327
91. Taylor-Jones JM, McGehee RE, Rando TA, Lecka-Czernik B, Lipschitz DA, Peterson CA (2002) Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev 123:649-661
92. Cordani N, Pisa V, Pozzi L, Sciorati C, Clementi E (2014) Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem Cells 32:874-885
93. Bosnakovski D, Xu Z, Li W, Thet S, Cleaver O, Perlingeiro RC, Kyba M (2008) Prospective isolation of skeletal muscle stem cells with a Pax7 reporter. Stem Cells 26:3194-3204
94. Fukada S, Higuchi S, Segawa M, Koda K, Yamamoto Y, Tsujikawa K, Kohama Y, Uezumi A, Imamura M, Miyagoe-Suzuki Y, Takeda S, Yamamoto H (2004) Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp Cell Res 296:245-255
95. Fukada S, Ma Y, Ohtani T, Watanabe Y, Murakami S, Yamaguchi M (2013) Isolation, characterization, and molecular regulation of muscle stem cells. Front Physiol 4:317
96. Blanco-Bose WE, Yao CC, Kramer RH, Blau HM (2001) Purification of mouse primary myoblasts based on alpha 7 integrin expression. Exp Cell Res 265:212-220
97. Sherwood RI, Christensen JL, Conboy IM, Conboy MJ, Rando TA, Weissman IL, Wagers AJ (2004) Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119:543-554
98. Tanaka KK, Hall JK, Troy AA, Cornelison DD, Majka SM, Olwin BB (2009) Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 4:217-225
99. Pisani DF, Dechesne CA, Sacconi S, Delplace S, Belmonte N, Cochet O, Clement N, Wdziekonski B, Villageois AP, Butori C, Bagnis C, Di Santo JP, Kurzenne JY, Desnuelle C, Dani C (2010) Isolation of a highly myogenic CD34-negative subset of human skeletal muscle cells free of adipogenic potential. Stem Cells 28:753-764
100. Pisani DF, Clement N, Loubat A, Plaisant M, Sacconi S, Kurzenne JY, Desnuelle C, Dani C, Dechesne CA (2010) Hierarchization of myogenic and adipogenic progenitors within human skeletal muscle. Stem Cells 28:2182-2194
101. Tamaki T, Akatsuka A, Ando K, Nakamura Y, Matsuzawa H, Hotta T, Roy RR, Edgerton VR (2002) Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 157:571-577
102. Chen JC, Mortimer J, Marley J, Goldhamer DJ (2005) MyoD-cre transgenic mice: a model for conditional mutagenesis and lineage tracing of skeletal muscle. Genesis 41:116-121
103. Starkey JD, Yamamoto M, Yamamoto S, Goldhamer DJ (2011) Skeletal muscle satellite cells are committed to myogenesis and do not spontaneously adopt nonmyogenic fates. J Histochem Cytochem 59:33-46
104. Schulz TJ, Huang TL, Tran TT, Zhang H, Townsend KL, Shadrach JL, Cerletti M, McDougall LE, Giorgadze N, Tchkonia T, Schrier D, Falb D, Kirkland JL, Wagers AJ, Tseng YH (2010) Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci U S A 108:143-148
105. Yin H, Pasut A, Soleimani VD, Bentzinger CF, Antoun G, Thorn S, Seale P, Fernando P, van Ijcken W, Grosveld F, Dekemp RA, Boushel R, Harper ME, Rudnicki MA (2013) MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16. Cell Metab 17:210-224
106. Shan T, Liang X, Bi P, Zhang P, Liu W, Kuang S (2013) Distinct populations of adipogenic and myogenic Myf5-lineage progenitors in white adipose tissues. J Lipid Res 54:2214-2224
107. Mizuno H (2009) The potential for treatment of skeletal muscle disorders with adipose-derived stem cells. Curr Stem Cell Res Ther 5:133-136
108. Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K (2010) Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 12:143-152
109. Mozzetta C, Consalvi S, Saccone V, Tierney M, Diamantini A, Mitchell KJ, Marazzi G, Borsellino G, Battistini L, Sassoon D, Sacco A, Puri PL (2013) Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med 5:626-639
110. Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM, Rando TA, Chawla A (2013) Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153:376-388
111. Uezumi A, Ito T, Morikawa D, Shimizu N, Yoneda T, Segawa M, Yamaguchi M, Ogawa R, Matev MM, Miyagoe-Suzuki Y, Takeda S, Tsujikawa K, Tsuchida K, Yamamoto H, Fukada S (2011) Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci 124:3654-3664
112. Saccone V, Consalvi S, Giordani L, Mozzetta C, Barozzi I, Sandona M, Ryan T, Rojas-Munoz A, Madaro L, Fasanaro P, Borsellino G, De Bardi M, Frige G, Termanini A, Sun X, Rossant J, Bruneau BG, Mercola M, Minucci S, Puri PL (2014) HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev 28:841-857
113. Uezumi A, Fukada S, Yamamoto N, Ikemoto-Uezumi M, Nakatani M, Morita M, Yamaguchi A, Yamada H, Nishino I, Hamada Y, Tsuchida K (2014) Identification and characterization of PDGFRalpha+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis 5:e1186
114. Ito T, Ogawa R, Uezumi A, Ohtani T, Watanabe Y, Tsujikawa K, Miyagoe-Suzuki Y, Takeda S, Yamamoto H, Fukada S (2013) Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors. Neuromuscul Disord 23:349-356
115. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-394
116. Muskiewicz KR, Frank NY, Flint AF, Gussoni E (2005) Myogenic potential of muscle side and main population cells after intravenous injection into sub-lethally irradiated mdx mice. J Histochem Cytochem 53:861-873
117. Pavlath GK, Gussoni E (2005) Human myoblasts and muscle-derived SP cells. Methods Mol Med 107:97-110
118. Jackson KA, Mi T, Goodell MA (1999) Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A 96:14482-14486
119. Asakura A, Seale P, Girgis-Gabardo A, Rudnicki MA (2002) Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159:123-134
120. Huang P, Schulz TJ, Beauvais A, Tseng YH, Gussoni E (2014) Intramuscular adipogenesis is inhibited by myo-endothelial progenitors with functioning Bmpr1a signalling. Nat Commun 5:4063
121. Zheng B, Cao B, Crisan M, Sun B, Li G, Logar A, Yap S, Pollett JB, Drowley L, Cassino T, Gharaibeh B, Deasy BM, Huard J, Peault B (2007) Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 25:1025-1034
122. Crisan M, Deasy B, Gavina M, Zheng B, Huard J, Lazzari L, Peault B (2008) Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol 86:295-309
123. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L, Innocenzi A, Galvez BG, Messina G, Morosetti R, Li S, Belicchi M, Peretti G, Chamberlain JS, Wright WE, Torrente Y, Ferrari S, Bianco P, Cossu G (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9:255-267
124. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE (2004) Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110:2226-2232
125. Birbrair A, Zhang T, Wang ZM, Messi ML, Enikolopov GN, Mintz A, Delbono O (2012) Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res 10:67-84
126. Birbrair A, Zhang T, Wang ZM, Messi ML, Enikolopov GN, Mintz A, Delbono O (2013) Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells Dev 22:2298-2314
127. Tonlorenzi R, Dellavalle A, Schnapp E, Cossu G, Sampaolesi M (2007) Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. Curr Protoc Stem Cell Biol Chapter 2: Unit 2B 1
128. Cossu G, Bianco P (2003) Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev 13:537-542
129. Roobrouck VD, Clavel C, Jacobs SA, Ulloa-Montoya F, Crippa S, Sohni A, Roberts SJ, Luyten FP, Van Gool SW, Sampaolesi M, Delforge M, Luttun A, Verfaillie CM (2011) Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 29:871-882
130. Messina G, Sirabella D, Monteverde S, Galvez BG, Tonlorenzi R, Schnapp E, De Angelis L, Brunelli S, Relaix F, Buckingham M, Cossu G (2009) Skeletal muscle differentiation of embryonic mesoangioblasts requires pax3 activity. Stem Cells 27:157-164
131. Sciorati C, Galvez BG, Brunelli S, Tagliafico E, Ferrari S, Cossu G, Clementi E (2006) Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J Cell Sci 119:5114-5123
132. Bosurgi L, Corna G, Vezzoli M, Touvier T, Cossu G, Manfredi AA, Brunelli S, Rovere-Querini P (2012) Transplanted mesoangioblasts require macrophage IL-10 for survival in a mouse model of muscle injury. J Immunol 188:6267-6277
133. Mitchell KJ, Pannerec A, Cadot B, Parlakian A, Besson V, Gomes ER, Marazzi G, Sassoon DA (2010) Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 12:257-266
134. Pannerec A, Formicola L, Besson V, Marazzi G, Sassoon DA (2013) Defining skeletal muscle resident progenitors and their cell fate potentials. Development 140:2879-2891
135. Sanderson RD, Fitch JM, Linsenmayer TR, Mayne R (1986) Fibroblasts promote the formation of a continuous basal lamina during myogenesis in vitro. J Cell Biol 102:740-747
136. Archile-Contreras AC, Mandell IB, Purslow PP (2010) Phenotypic differences in matrix metalloproteinase 2 activity between fibroblasts from 3 bovine muscles. J Anim Sci 88:4006-4015
137. Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127:526-537
138. Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL, Munoz-Canoves P (2011) Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 1:21
139. Murphy MM, Lawson JA, Mathew SJ, Hutcheson DA, Kardon G (2011) Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138:3625-3637
140. Alexakis C, Partridge T, Bou-Gharios G (2007) Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol 293:C661-C669
141. Serrano AL, Munoz-Canoves P (2010) Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res 316:3050-3058
142. Green H, Meuth M (1974) An established pre-adipose cell line and its differentiation in culture. Cell 3:127-133
143. O'Shea Alvarez MS (1991) 3T3 cells in adipocytic conversion. Arch Invest Med (Mex) 22:235-244
144. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676
145. Goodpaster T, Legesse-Miller A, Hameed MR, Aisner SC, Randolph-Habecker J, Coller HA (2008) An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 56:347-358
146. Agley CC, Rowlerson AM, Velloso CP, Lazarus NR, Harridge SD (2013) Human skeletal muscle fibroblasts, but not myogenic cells, readily undergo adipogenic differentiation. J Cell Sci 126:5610-5625
147. Roberts EW, Deonarine A, Jones JO, Denton AE, Feig C, Lyons SK, Espeli M, Kraman M, McKenna B, Wells RJ, Zhao Q, Caballero OL, Larder R, Coll AP, O'Rahilly S, Brindle KM, Teichmann SA, Tuveson DA, Fearon DT (2013) Depletion of stromal cells expressing fibroblast activation protein-alpha from skeletal muscle and bone marrow results in cachexia and anemia. J Exp Med 210:1137-1151
148. Olson LE, Soriano P (2009) Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Dev Cell 16:303-313
149. Cawthorn WP, Scheller EL, MacDougald OA (2011) Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res 53:227-246
150. Duguez S, Feasson L, Denis C, Freyssenet D (2002) Mitochondrial biogenesis during skeletal muscle regeneration. Am J Physiol Endocrinol Metab 282:E802-E809
151. Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K, Franzin C, Cortivo R, Rossato M, Vettor R, Abatangelo G, Pozzan T, Pinton P, Rizzuto R (2008) High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci U S A 105:1226-1231
152. Yue T, Yin J, Li F, Li D, Du M (2010) High glucose induces differentiation and adipogenesis in porcine muscle satellite cells via mTOR. BMB Rep 43:140-145
153. Powell DJ, McFarland DC, Cowieson AJ, Muir WI, Velleman SG (2014) The effect of nutritional status and muscle fiber type on myogenic satellite cell fate and apoptosis. Poult Sci 93:163-173
154. Radley HG, De Luca A, Lynch GS, Grounds MD (2007) Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int J Biochem Cell Biol 39:469-477
155. Sunadome K, Suzuki T, Usui M, Ashida Y, Nishida E (2014) Antagonism between the master regulators of differentiation ensures the discreteness and robustness of cell fates. Mol Cell 54:526-535
156. Cisternas P, Vio CP, Inestrosa NC (2014) Role of Wnt signaling in tissue fibrosis, lessons from skeletal muscle and kidney. Curr Mol Med 14:510-522
157. von Maltzahn J, Chang NC, Bentzinger CF, Rudnicki MA (2012) Wnt signaling in myogenesis. Trends Cell Biol 22:602-609
158. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA (2000) Inhibition of adipogenesis by Wnt signaling. Science 289:950-953
159. Vertino AM, Taylor-Jones JM, Longo KA, Bearden ED, Lane TF, McGehee RE Jr, MacDougald OA, Peterson CA (2005) Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol Biol Cell 16:2039-2048
160. Itoigawa Y, Kishimoto KN, Sano H, Kaneko K, Itoi E (2011) Molecular mechanism of fatty degeneration in rotator cuff muscle with tendon rupture. J Orthop Res 29:861-866
161. Pedersen BK (2011) Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun 25:811-816
162. Raschke S, Eckardt K, Bjorklund Holven K, Jensen J, Eckel J (2013) Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells. Plos One 8:e62008
163. Rotter V, Nagaev I, Smith U (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784
164. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA (2003) Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52:2784-2789
165. Raschke S, Eckel J (2013) Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators Inflamm 2013:320724
166. Pedersen BK, Steensberg A, Schjerling P (2001) Muscle-derived interleukin-6: possible biological effects. J Physiol 536:329-337
167. Park S, Baek K, Choi C (2013) Suppression of adipogenic differentiation by muscle cell-induced decrease in genes related to lipogenesis in muscle and fat co-culture system. Cell Biol Int 37:1003-1009
168. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83-90
169. Ruegg UT (2013) Pharmacological prospects in the treatment of Duchenne muscular dystrophy. Curr Opin Neurol 26:577-584
170. Artaza JN, Bhasin S, Magee TR, Reisz-Porszasz S, Shen R, Groome NP, Meerasahib MF, Gonzalez-Cadavid NF (2005) Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146:3547-3557
171. McPherron AC, Lee SJ (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109:595-601
172. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L (2003) Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol 23:7230-7242
173. Li F, Yang H, Duan Y, Yin Y (2011) Myostatin regulates preadipocyte differentiation and lipid metabolism of adipocyte via ERK1/2. Cell Biol Int 35:1141-1146
174. Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP (2009) Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 297:E157-E164
175. Flanagan JN, Linder K, Mejhert N, Dungner E, Wahlen K, Decaunes P, Ryden M, Bjorklund P, Arver S, Bhasin S, Bouloumie A, Arner P, Dahlman I (2009) Role of follistatin in promoting adipogenesis in women. J Clin Endocrinol Metab 94:3003-3009
176. Braga M, Reddy ST, Vergnes L, Pervin S, Grijalva V, Stout D, David J, Li X, Tomasian V, Reid CB, Norris KC, Devaskar SU, Reue K, Singh R (2014) Follistatin promotes adipocyte differentiation, browning, and energy metabolism. J Lipid Res 55:375-384
177. Braga M, Pervin S, Norris K, Bhasin S, Singh R (2013) Inhibition of in vitro and in vivo brown fat differentiation program by myostatin. Obesity (Silver Spring) 21:1180-1188
178. Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E, Stantzou A, Mouisel E, Toniolo L, Ferry A, Stricker S, Goldberg AL, Dupont S, Piccolo S, Amthor H, Sandri M (2013) BMP signaling controls muscle mass. Nat Genet 45:1309-1318
179. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A (1999) Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274:19838-19845
180. Huang P, Schulz TJ, Beauvais A, Tseng YH, Gussoni E (2014) Intramuscular adipogenesis is inhibited by myo-endothelial progenitors with functioning Bmpr1a signalling. Nat Commun 5:4063
181. Sartori R, Gregorevic P, Sandri M (2014) TGFbeta and BMP signaling in skeletal muscle: potential significance for muscle-related disease. Trends Endocrinol Metab 25:464-471
182. Kawai M, Rosen CJ (2010) The IGF-I regulatory system and its impact on skeletal and energy homeostasis. J Cell Biochem 111:14-19
183. Sordella R, Jiang W, Chen GC, Curto M, Settleman J (2003) Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 113:147-158
184. Kjaer M (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84:649-698
185. Gillies AR, Lieber RL (2011) Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve 44:318-331
186. Kaariainen M, Jarvinen T, Jarvinen M, Rantanen J, Kalimo H (2000) Relation between myofibers and connective tissue during muscle injury repair. Scand J Med Sci Sports 10:332-337
187. Boldrin L, Elvassore N, Malerba A, Flaibani M, Cimetta E, Piccoli M, Baroni MD, Gazzola MV, Messina C, Gamba P, Vitiello L, De Coppi P (2007) Satellite cells delivered by micro-patterned scaffolds: a new strategy for cell transplantation in muscle diseases. Tissue Eng 13:253-262
188. Kshitiz, Park J, Kim P, Helen W, Engler AJ, Levchenko A, Kim DH (2012) Control of stem cell fate and function by engineering physical microenvironments. Integr Biol (Camb) 4:1008-1018
189. Xaymardan M, Gibbins JR, Zoellne H (2002) Adipogenic healing in adult mice by implantation of hollow devices in muscle. Anat Rec 267:28-36
190. Bellayr I, Holden K, Mu X, Pan H, Li Y (2013) Matrix metalloproteinase inhibition negatively affects muscle stem cell behavior. Int J Clin Exp Pathol 6:124-141
191. Sabatelli P, Gualandi F, Gara SK, Grumati P, Zamparelli A, Martoni E, Pellegrini C, Merlini L, Ferlini A, Bonaldo P, Maraldi NM, Paulsson M, Squarzoni S, Wagener R (2012) Expression of collagen VI alpha5 and alpha6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis. Matrix Biol 31:187-196
192. Sul HS, Smas CM, Wang D, Chen L (1998) Regulation of fat synthesis and adipose differentiation. Prog Nucleic Acid Res Mol Biol 60:317-345
193. Nakajima I, Yamaguchi T, Ozutsumi K, Aso H (1998) Adipose tissue extracellular matrix: newly organized by adipocytes during differentiation. Differentiation 63:193-200
194. Yi T, Choi HM, Park RW, Sohn KY, Kim IS (2001) Transcriptional repression of type I procollagen genes during adipocyte differentiation. Exp Mol Med 33:269-275
195. Kubo Y, Kaidzu S, Nakajima I, Takenouchi K, Nakamura F (2000) Organization of extracellular matrix components during differentiation of adipocytes in long-term culture. In Vitro Cell Dev Biol Anim 36:38-44
196. Ibrahimi A, Bonino F, Bardon S, Ailhaud G, Dani C (1992) Essential role of collagens for terminal differentiation of preadipocytes. Biochem Biophys Res Commun 187:1314-1322
197. Ward M, Ajuwon KM (2011) Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin. Cell Prolif 44:343-351
198. Kawaguchi N, Toriyama K, Nicodemou-Lena E, Inou K, Torii S, Kitagawa Y (1998) De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc Natl Acad Sci U S A 95:1062-1066
199. Rigamonti E, Zordan P, Sciorati C, Rovere-Querini P, Brunelli S (2014) Macrophage plasticity in skeletal muscle repair. Biomed Res Int 2014:560629
200. Segawa M, Fukada S, Yamamoto Y, Yahagi H, Kanematsu M, Sato M, Ito T, Uezumi A, Hayashi S, Miyagoe-Suzuki Y, Takeda S, Tsujikawa K, Yamamoto H (2008) Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. Exp Cell Res 314:3232-3244
201. Malerba A, Vitiello L, Segat D, Dazzo E, Frigo M, Scambi I, De Coppi P, Boldrin L, Martelli L, Pasut A, Romualdi C, Bellomo RG, Vecchiet J, Baroni MD (2009) Selection of multipotent cells and enhanced muscle reconstruction by myogenic macrophage-secreted factors. Exp Cell Res 315:915-927
202. Corna G, Campana L, Pignatti E, Castiglioni A, Tagliafico E, Bosurgi L, Campanella A, Brunelli S, Manfredi AA, Apostoli P, Silvestri L, Camaschella C, Rovere-Querini P (2010) Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 95:1814-1822
203. Campana L, Santarella F, Esposito A, Maugeri N, Rigamonti E, Monno A, Canu T, Del Maschio A, Bianchi ME, Manfredi AA, Rovere-Querini P (2014) Leukocyte HMGB1 is required for vessel remodeling in regenerating muscles. J Immunol 192:5257-5264
204. Zordan P, Rigamonti E, Freudenberg K, Conti V, Azzoni E, Rovere-Querini P, Brunelli S (2014) Macrophages commit postnatal endothelium-derived progenitors to angiogenesis and restrict endothelial to mesenchymal transition during muscle regeneration. Cell Death Dis 5:e1031
205. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8:301-309
206. Hill AA, Reid Bolus W, Hasty AH (2014) A decade of progress in adipose tissue macrophage biology. Immunol Rev 262:134-152
207. Zordan P, Sciorati C, Campana L, Cottone L, Clementi E, Querini PR, Brunelli S (2013) The nitric oxide-donor molsidomine modulates the innate inflammatory response in a mouse model of muscular dystrophy. Eur J Pharmacol 715:296-303
208. Rigamonti E, Touvier T, Clementi E, Manfredi AA, Brunelli S, Rovere-Querini P (2013) Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J Immunol 190:1767-1777
209. Stamler JS, Meissner G (2001) Physiology of nitric oxide in skeletal muscle. Physiol Rev 81:209-237
210. Clementi E, Meldolesi J (1997) The cross-talk between nitric oxide and Ca2 +: a story with a complex past and a promising future. Trends Pharmacol Sci 18:266-269
211. Clementi E, Borgese N, Meldolesi J (2003) Interactions between nitric oxide and sphingolipids and the potential consequences in physiology and pathology. Trends Pharmacol Sci 24:518-523
212. Ascenzi P, di Masi A, Sciorati C, Clementi E (2010) Peroxynitrite-An ugly biofactor? BioFactors 36:264-273
213. Filippin LI, Moreira AJ, Marroni NP, Xavier RM (2009) Nitric oxide and repair of skeletal muscle injury. Nitric Oxide 21:157-163
214. De Palma C, Clementi E (2012) Nitric oxide in myogenesis and therapeutic muscle repair. Mol Neurobiol 46:682-692
215. Kaminski HJ, Andrade FH (2001) Nitric oxide: biologic effects on muscle and role in muscle diseases. Neuromuscul Disord 11:517-524
216. Nisoli E, Carruba MO (2006) Nitric oxide and mitochondrial biogenesis. J Cell Sci 119:2855-2862
217. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743-752
218. Gucuyener K, Ergenekon E, Erbas D, Pinarli G, Serdaroglu A (2000) The serum nitric oxide levels in patients with Duchenne muscular dystrophy. Brain Dev 22:181-183
219. Sciorati C, Buono R, Azzoni E, Casati S, Ciuffreda P, D'Angelo G, Cattaneo D, Brunelli S, Clementi E (2010) Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans. Br J Pharmacol 160:1550-1560
220. Tidball JG, Wehling-Henricks M (2004) Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Mol Genet Metab 82:312-320
221. Brunelli S, Sciorati C, D'Antona G, Innocenzi A, Covarello D, Galvez BG, Perrotta C, Monopoli A, Sanvito F, Bottinelli R, Ongini E, Cossu G, Clementi E (2007) Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci U S A 104:264-269
222. Sciorati C, Miglietta D, Buono R, Pisa V, Cattaneo D, Azzoni E, Brunelli S, Clementi E (2011) A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy. Pharmacol Res 64:210-217
223. Brunelli S, Rovere-Querini P, Sciorati C, Manfredi AA, Clementi E (2007) Nitric oxide: emerging concepts about its use in cell-based therapies. Expert Opin Investig Drugs 16:33-43
224. D'Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E (2012) Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients. Pharmacol Res 65:472-479
225. Buono R, Vantaggiato C, Pisa V, Azzoni E, Bassi MT, Brunelli S, Sciorati C, Clementi E (2011) Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP. Stem Cells 30:197-209
226. De Palma C, Falcone S, Pisoni S, Cipolat S, Panzeri C, Pambianco S, Pisconti A, Allevi R, Bassi MT, Cossu G, Pozzan T, Moncada S, Scorrano L, Brunelli S, Clementi E (2010) Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation. Cell Death Differ 17:1684-1696
227. Anderson JE (2000) A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell 11:1859-1874
228. Drenning JA, Lira VA, Simmons CG, Soltow QA, Sellman JE, Criswell DS (2008) Nitric oxide facilitates NFAT-dependent transcription in mouse myotubes. Am J Physiol Cell Physiol 294:C1088-C1095
229. Colussi C, Mozzetta C, Gurtner A, Illi B, Rosati J, Straino S, Ragone G, Pescatori M, Zaccagnini G, Antonini A, Minetti G, Martelli F, Piaggio G, Gallinari P, Steinkuhler C, Clementi E, Dell'Aversana C, Altucci L, Mai A, Capogrossi MC, Puri PL, Gaetano C (2008) HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A 105:19183-19187
230. Clementi E, Brown GC, Foxwell N, Moncada S (1999) On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci U S A 96:1559-1562
231. Clementi E, Brown GC, Feelisch M, Moncada S (1998) Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A 95:7631-7636
232. Dai Z, Wu Z, Yang Y, Wang J, Satterfield MC, Meininger CJ, Bazer FW, Wu G (2013) Nitric oxide and energy metabolism in mammals. BioFactors 39:383-391
233. Nisoli E, Clementi E, Tonello C, Sciorati C, Briscini L, Carruba MO (1998) Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures. Br J Pharmacol 125:888-894
234. Kang C, Li Ji L (2012) Role of PGC-1alpha signaling in skeletal muscle health and disease. Ann N Y Acad Sci 1271:110-117
235. Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E, Minetti G, Zhao P, Hoffman EP, Puri PL, Sartorelli V (2004) Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell 6:673-684
236. Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V, Fortuni S, Straino S, Sampaolesi M, Di Padova M, Illi B, Gallinari P, Steinkuhler C, Capogrossi MC, Sartorelli V, Bottinelli R, Gaetano C, Puri PL (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 12:1147-1150
237. Saccone V, Consalvi S, Giordani L, Mozzetta C, Barozzi I, Sandona M, Ryan T, Rojas-Munoz A, Madaro L, Fasanaro P, Borsellino G, De Bardi M, Frige G, Termanini A, Sun X, Rossant J, Bruneau BG, Mercola M, Minucci S, Puri PL (2014) HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev 28:841-857
238. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233
239. Twayana S, Legnini I, Cesana M, Cacchiarelli D, Morlando M, Bozzoni I (2013) Biogenesis and function of non-coding RNAs in muscle differentiation and in Duchenne muscular dystrophy. Biochem Soc Trans 41:844-849
240. Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M, Cardani R, Perbellini R, Isaia E, Sale P, Meola G, Capogrossi MC, Gaetano C, Martelli F (2009) Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J 23:3335-3346
241. Cacchiarelli D, Legnini I, Martone J, Cazzella V, D'Amico A, Bertini E, Bozzoni I (2011) miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med 3:258-265
242. Motohashi N, Alexander MS, Casar JC, Kunkel LM (2012) Identification of a novel microRNA that regulates the proliferation and differentiation in muscle side population cells. Stem Cells Dev 21:3031-3043
243. Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A, Sinagra G, Giacca M (2004) Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 10:844-854
244. Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C (2009) Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 68:762-773
245. Tan JT, McLennan SV, Song WW, Lo LW, Bonner JG, Williams PF, Twigg SM (2008) Connective tissue growth factor inhibits adipocyte differentiation. Am J Physiol Cell Physiol 295:C740-C751
246. Fitter S, Vandyke K, Gronthos S, Zannettino AC (2012) Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion. J Mol Endocrinol 48:229-240